SOUTH KOREA – SK Inc. of South Korea has committed US$350 million in equity financing to the Center for Breakthrough Medicines (CBM) as part of the organizations’ partnership announced two…
Read MoreTag: CDMO
Sterling Pharma Solutions ramps up manufacturing capacity with £10m investment
UNITED KINGDOM – Sterling Pharma Solutions, a contract development and manufacturing firm, has announced a £10 million (US$13.5 million) multi-year investment strategy for its Dudley, UK, facility. This latest investment,…
Read MoreGenScript opens first fully-automated gene therapy manufacturing plant in US
USA – The world’s leading provider of life science research tools and services, GenScript has announced the opening of a more than 50,000-square-foot facility for highly automated gene synthesis and…
Read MoreBionova Scientific opens new biologics plant in Fremont, CA
USA – Bionova Scientific, a biologics contract development and manufacturing organization (CDMO) with extensive protein production, cell line development, process development, and analytical expertise, has opened a commercial-ready fully single-use…
Read MoreRentschler Biopharma, XL-Protein tie up deal to manufacture therapeutic DNase I
GERMANY – Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, and XL-protein, a privately held biopharmaceutical company in Germany, have formed a partnership to develop…
Read MoreGTP Bioways invests US$14 million in biopharma production lines
FRANCE – GTP Bioways, a contract development and manufacturing organization (CDMO) specializing in biotherapies and nanotherapies, is set to invest US$14 million in two new biopharmaceutical production lines at its…
Read More